A recent review published in Nutrients evaluates the physiological role of vitamin D during the first 1,000 days of human life, applying the Developmental Origins of Health and Disease (DOHaD) framework.
Unpacking Vitamin D's Role in Early Life: A DOHaD Perspective
Early-life vitamin D is considered essential for the nutritional prevention of skeletal diseases such as rickets. The review highlights crucial data, indicating that vitamin D influences over 1,000 genes through the nuclear vitamin D receptor (VDR).
The review highlights data indicating that vitamin D influences over 1,000 genes through the nuclear vitamin D receptor (VDR), suggesting potential relevance to immune, metabolic, and neurodevelopmental health.
While vitamin D exhibits biological plausibility as an early-life programming factor, current human clinical evidence for non-skeletal outcomes is developing and incomplete, leading to varied and context-dependent findings.
Background: The Critical First 1,000 Days
The first 1,000 days of a newborn’s life are recognized as a period where environmental stimuli significantly shape long-term health trajectories. Vitamin D, historically studied for its role in calcium-phosphate homeostasis, has shown significant extraskeletal effects in more recent research.
Despite its critical role, vitamin D deficiency remains a global health concern, affecting an estimated 28% of the population. Pregnant populations are particularly vulnerable, with 54% demonstrating serum 25(OH)D levels below 20 ng/mL. Neonatal vitamin D stores are largely dependent on maternal transfer, suggesting maternal deficiency may predispose infants to adverse outcomes.
Review Methodology
This narrative review synthesized recent literature investigating the impacts of vitamin D across pregnancy, early life, infancy, and toddlerhood. Studies were identified from PubMed, Scopus, and Cochrane databases, including systematic reviews, meta-analyses, randomized controlled trials (RCTs), and high-quality observational studies.
Key outcomes investigated included:
- Biomarkers: Serum 25(OH)D concentrations.
- Skeletal Outcomes: Bone mineral content (BMC) and bone mineral density (BMD).
- Immune and Metabolic Indicators: Acute respiratory tract infections (ARTIs) and body mass index (BMI).
- Molecular Pathways: Transcriptomics and epigenetics.
The analyses also examined varying vitamin D dosing regimens, from standard 400 IU/day supplementation to high-dose maternal interventions of 6,400 IU/day during lactation.
Specific Findings
- Skeletal Development: Supplementation with 1,000 IU/day during pregnancy increased neonatal whole-body BMC, with some persistence into mid-childhood.
- Immune Regulation: Meta-analyses involving over 48,000 participants showed a small reduction in ARTI risk with vitamin D supplementation, particularly at doses of 400-1,000 IU daily. Effects were not significant in infants under 1 year old.
- Metabolic and Birth Outcomes: Observational studies involving over 35,000 mother-offspring pairs linked low maternal 25(OH)D levels to higher risks of small-for-gestational-age (SGA) infants and lower birth weights. Randomized trial data, however, remain inconsistent.
- Molecular Programming: Maternal supplementation was associated with reduced epigenetic gestational age acceleration and altered placental gene expression, though clinical implications require further clarification.
Conclusions and Future Directions
The review supports vitamin D’s biological plausibility as an early-life nutritional programming factor. Its role extends beyond skeletal health to immune tolerance and possible neurodevelopmental effects, although evidence for these outcomes remains developing and heterogeneous.
The 2024 Endocrine Society guidelines suggest empiric supplementation during pregnancy at approximately 2,500 IU/day, while emphasizing that non-skeletal benefits are not yet definitive.
Future research should adopt precision nutrition approaches that consider genetic variation, including polymorphisms in the vitamin D-binding protein (DBP), which may influence individual responses to supplementation.